92 related articles for article (PubMed ID: 12606657)
21. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
Jiménez E; Montiel M
J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
[TBL] [Abstract][Full Text] [Related]
22. Characterization of two second messenger pathways and their interactions in eliciting the human sperm acrosome reaction.
Doherty CM; Tarchala SM; Radwanska E; De Jonge CJ
J Androl; 1995; 16(1):36-46. PubMed ID: 7768751
[TBL] [Abstract][Full Text] [Related]
23. Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice.
Bernstein MA; Welch SP
Drug Alcohol Depend; 1997 Jan; 44(1):41-6. PubMed ID: 9031819
[TBL] [Abstract][Full Text] [Related]
24. PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice.
Smith FL; Javed RR; Smith PA; Dewey WL; Gabra BH
Pharmacol Res; 2006 Dec; 54(6):474-80. PubMed ID: 17056270
[TBL] [Abstract][Full Text] [Related]
25. PKA and CaMKII mediate PI3K activation in bovine sperm by inhibition of the PKC/PP1 cascade.
Rotfeld H; Hillman P; Ickowicz D; Breitbart H
Reproduction; 2014 Mar; 147(3):347-56. PubMed ID: 24398875
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase A.
Defauw JM; Murphy MM; Jagdmann GE; Hu H; Lampe JW; Hollinshead SP; Mitchell TJ; Crane HM; Heerding JM; Mendoza JS; Davis JE; Darges JW; Hubbard FR; Hall SE
J Med Chem; 1996 Dec; 39(26):5215-27. PubMed ID: 8978850
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological profile of delta 9-THC carbamate.
Little PJ; Kaplan NC; Martin BR
Alcohol Drug Res; 1987; 7(5-6):517-23. PubMed ID: 3040025
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation.
Koh WS; Crawford RB; Kaminski NE
Biochem Pharmacol; 1997 May; 53(10):1477-84. PubMed ID: 9260875
[TBL] [Abstract][Full Text] [Related]
29. Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance.
Gabra BH; Bailey CP; Kelly E; Sanders AV; Henderson G; Smith FL; Dewey WL
Brain Res; 2007 Jul; 1159():86-93. PubMed ID: 17582387
[TBL] [Abstract][Full Text] [Related]
30. Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.
Stadelmann AM; Juckel G; Arning L; Gallinat J; Epplen JT; Roser P
Neurosci Lett; 2011 May; 496(1):60-4. PubMed ID: 21513772
[TBL] [Abstract][Full Text] [Related]
31. The expression of a high level of morphine antinociceptive tolerance in mice involves both PKC and PKA.
Smith FL; Javed RR; Elzey MJ; Dewey WL
Brain Res; 2003 Sep; 985(1):78-88. PubMed ID: 12957370
[TBL] [Abstract][Full Text] [Related]
32. PKC and PKA inhibitors reverse tolerance to morphine-induced hypothermia and supraspinal analgesia in mice.
Javed RR; Dewey WL; Smith PA; Smith FL
Eur J Pharmacol; 2004 May; 492(2-3):149-57. PubMed ID: 15178359
[TBL] [Abstract][Full Text] [Related]
33. Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions.
Rubino T; Vigano' D; Massi P; Spinello M; Zagato E; Giagnoni G; Parolaro D
Neuropharmacology; 2000 Apr; 39(7):1331-6. PubMed ID: 10760375
[TBL] [Abstract][Full Text] [Related]
34. Antinociceptive activity of Delta9-tetrahydrocannabinol non-ionic microemulsions.
Lazzari P; Fadda P; Marchese G; Casu GL; Pani L
Int J Pharm; 2010 Jun; 393(1-2):238-43. PubMed ID: 20399844
[TBL] [Abstract][Full Text] [Related]
35. The effect of PKA-phosphorylation on the structure of inhibitor-1 studied by NMR spectroscopy.
Huang YC; Chen YC; Tsay HJ; Chyan CL; Chen CY; Huang HB; Lin TH
J Biochem; 2010 Feb; 147(2):273-8. PubMed ID: 19887526
[TBL] [Abstract][Full Text] [Related]
36. Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice.
Gabra BH; Bailey CP; Kelly E; Smith FL; Henderson G; Dewey WL
Brain Res; 2008 Jun; 1217():70-7. PubMed ID: 18501877
[TBL] [Abstract][Full Text] [Related]
37. Involvement of phospholipid signal transduction pathways in morphine tolerance in mice.
Smith FL; Lohmann AB; Dewey WL
Br J Pharmacol; 1999 Sep; 128(1):220-6. PubMed ID: 10498855
[TBL] [Abstract][Full Text] [Related]
38. Behavioral suppression induced by cannabinoids is due to activation of the arachidonic acid cascade in rats.
Yamaguchi T; Shoyama Y; Watanabe S; Yamamoto T
Brain Res; 2001 Jan; 889(1-2):149-54. PubMed ID: 11166698
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of spinal protein kinase C reduces nerve injury-induced tactile allodynia in neuropathic rats.
Hua XY; Chen P; Yaksh TL
Neurosci Lett; 1999 Dec; 276(2):99-102. PubMed ID: 10624801
[TBL] [Abstract][Full Text] [Related]
40. Aminoglutethimide, a steroidogenesis inhibitor, abolishes hormonal induction of ornithine decarboxylase in steroidogenic tissues: evidence for its role as cAMP-dependent protein kinase inhibitor.
Bastida CM; Tejada F; Cremades A; Peñafiel R
Biochem Biophys Res Commun; 2001 Feb; 281(1):244-8. PubMed ID: 11178987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
